Inhaled Brevetoxins: Health Effects and Mechanisms

吸入短尾毒素:健康影响和机制

基本信息

项目摘要

The major focus of this Project has been to examine the potential adverse health effects resulting from prolonged inhalation exposure to brevetoxins. The inhalation toxicities of a complex mixture of brevetoxins and brevetoxin antagonists in K. brevis extract was examined in rats, and the toxicity of pure brevetoxin 3 was examined in both rats and mice. Substantial immune suppression in rats, as indicated by a reduction in antibody response to immunization with sheep red blood cells, was consistently the primary response observed. Suppression of antibody forming responses occurred in the absence of frank toxicity to the spleen, changes in lymphocyte populations, or T cell responses to antigen. This immune suppression is important in light of reports in increased emergency room visits for pneumonia during Red Tide episodes identified by Fleming project and decreases in alveolar macrophage function in sheep inhaling brevetoxins in project by Abraham. This proposal will address the following specific aims: (1) To define exposure concentration-response relationships for brevetoxin-induced effects on humoral immunity in rats and to examine the role of macrophage cathepsin inhibition in mediating these effects; (2) To examine the effects of brevetoxin inhalation on recovery from infection in a rat model of influenza including young adult and aged rats; and (3) To determine the immunotoxic potential of brevetoxin in offspring of dams inhaling brevetoxins. These investigations will broaden examination of the exposure concentration-response relationship for brevetoxin-induced effects on antibody responses to antigen, provide insight into the underlying mechanism(s) for the observed immune suppression, examine potential consequences to brevetoxin-induced immune suppression on responses to viral infection; and determine the potential developmental immunotoxicity resulting from perinatal brevetoxin exposure.
该项目的主要重点是检查潜在的不良健康影响 由于长时间吸入对Brevetoxins的暴露而产生的。复杂混合物的吸入毒性 在大鼠中检查了K. brevis提取物中的Brevetoxin和Brevetoxin拮抗剂,纯净的毒性 在大鼠和小鼠中检查了Brevetoxin 3。大鼠的实质性免疫抑制,如 减少对绵羊红细胞免疫反应的抗体反应,始终是主要的 回应观察到。在没有坦率的毒性的情况下,发生抗体形成反应的抑制 脾脏,淋巴细胞种群的变化或T细胞对抗原的反应。这种免疫抑制是 鉴于在红潮情节期间急诊室就诊时增加的报告很重要 通过弗莱明(Fleming)项目鉴定,并在亚伯拉罕(Abraham)的绵羊吸入BrevEtoxins中的肺泡巨噬细胞功能下降。这 建议将解决以下特定目的:(1)定义暴露浓度 - 响应关系 对于brevetoxin诱导的对大鼠体液免疫的影响,并检查巨噬细胞组织蛋白酶的作用 抑制介导这些影响; (2)检查Brevetoxin吸入对从 流感大鼠模型中的感染包括年轻大鼠和老年大鼠; (3)确定免疫毒性 Brevetoxin在吸入Brevetoxins的后代的潜力。这些调查将扩大 检查Brevetoxin诱导抗体对抗原抗体反应的影响的暴露浓度响应关系,提供了对观察到的免疫抑制的潜在机制的见解, 检查对Brevetoxin诱导的免疫抑制对病毒感染的反应的潜在后果; 并确定围产期核毒素暴露引起的潜在发育免疫毒性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

JANET M. BENSON的其他基金

GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY
基因治疗资源计划 (GTRP):药理学和毒理学核心实验室
  • 批准号:
    10974184
    10974184
  • 财政年份:
    2023
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Inhaled Brevetoxins: Health Effects and Mechanisms
吸入短尾毒素:健康影响和机制
  • 批准号:
    7131154
    7131154
  • 财政年份:
    2006
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Animal models to assess efficacy of countermeasures for SM-induced toxicity
用于评估 SM 诱导毒性对策效果的动物模型
  • 批准号:
    7235097
    7235097
  • 财政年份:
    2006
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Inhaled brevetoxins--Health effects & toxicokinetics
吸入短毒素——对健康的影响
  • 批准号:
    6614504
    6614504
  • 财政年份:
    2002
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Inhaled brevetoxins--Health effects & toxicokinetics
吸入短毒素——对健康的影响
  • 批准号:
    6485252
    6485252
  • 财政年份:
    2001
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Inhaled brevetoxins--Health effects & toxicokinetics
吸入短毒素——对健康的影响
  • 批准号:
    6564459
    6564459
  • 财政年份:
    2001
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Inhaled brevetoxins--Health effects & toxicokinetics
吸入短毒素——对健康的影响
  • 批准号:
    6361817
    6361817
  • 财政年份:
    2000
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Animal models to assess efficacy of countermeasures for SM-induced toxicity
用于评估 SM 诱导毒性对策效果的动物模型
  • 批准号:
    7727024
    7727024
  • 财政年份:
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Inhaled Brevetoxins: Health Effects and Mechanisms
吸入短尾毒素:健康影响和机制
  • 批准号:
    7879343
    7879343
  • 财政年份:
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Animal models to assess efficacy of countermeasures for SM-induced toxicity
用于评估 SM 诱导毒性对策效果的动物模型
  • 批准号:
    8120836
    8120836
  • 财政年份:
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Innate and adaptive immunity in COPD exacerbations
COPD 恶化时的先天免疫和适应性免疫
  • 批准号:
    7660319
    7660319
  • 财政年份:
    2005
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Innate and adaptive immunity in COPD exacerbations
COPD 恶化时的先天免疫和适应性免疫
  • 批准号:
    7266310
    7266310
  • 财政年份:
    2005
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Innate and adaptive immunity in COPD exacerbations
COPD 恶化时的先天免疫和适应性免疫
  • 批准号:
    7467350
    7467350
  • 财政年份:
    2005
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Inhaled Brevetoxins: Health Effects and Mechanisms
吸入短尾毒素:健康影响和机制
  • 批准号:
    7879343
    7879343
  • 财政年份:
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别:
Inhaled Brevetoxins: Health Effects and Mechanisms
吸入短尾毒素:健康影响和机制
  • 批准号:
    8100259
    8100259
  • 财政年份:
  • 资助金额:
    $ 25.42万
    $ 25.42万
  • 项目类别: